Product Description
CRAMP (mouse) is an antibacterial peptide found in mouse, which is a peptide composed of 34 amino acids. CRAMP (mouse) In the blunt animal model, it can relieve the intestinal fibrosis of enteritis animals by inhibiting the expression and accumulation of collagen. It can be said that CRAMP (mouse) is an antimicrobial peptide in mouse that corresponds to LL-37 in humans.
AI Product Description
*The following content is generated by AI and is for reference only.
CRAMP, also known as Cathelicidin-related antimicrobial peptide or CRAMP (mouse), is a crucial component of the innate immune system in mice. It functions as a potent cationic antimicrobial peptide encoded by the Camp gene located on chromosome 10. The molecular formula for the murine CRAMP precursor protein is typically represented based on its amino acid sequence, which consists of 75 residues in its mature form after post-translational processing. While specific CAS numbers are often assigned to synthetic analogs or purified recombinant forms rather than the endogenous protein itself, synthetic versions used in research may carry unique identifiers for cataloging purposes. For instance, synthetic murine CRAMP peptides are frequently utilized in biochemical assays and drug development studies.
The primary biological role of CRAMP is to provide immediate defense against bacterial, fungal, and viral pathogens at mucosal surfaces such as the skin, respiratory tract, and gastrointestinal lining. Upon infection or tissue injury, epithelial cells rapidly upregulate CRAMP expression, releasing it into the extracellular environment where it disrupts microbial membranes through electrostatic interactions with negatively charged phospholipids. This mechanism leads to rapid pathogen lysis without triggering significant inflammatory responses, distinguishing it from other immune effectors. Beyond direct antimicrobial activity, CRAMP plays a regulatory role in wound healing and modulates inflammation by interacting with host receptors like TLR2 and TLR4.
In scientific research, synthetic mouse CRAMP is extensively employed to study host-pathogen interactions, evaluate novel antimicrobial strategies, and investigate the pathophysiology of sepsis and chronic infections. Researchers utilize this peptide to model human cathelicidin function, given the high homology between murine and human systems. Its stability and ease of synthesis make it an ideal candidate for in vitro and in vivo experiments aiming to enhance understanding of innate immunity. Furthermore, CRAMP derivatives are being explored as potential therapeutic agents for treating multidrug-resistant bacterial infections, offering hope for combating antibiotic resistance. As a fundamental molecule in immunology, CRAMP remains a vital subject for advancing knowledge in infectious disease management and developing next-generation antimicrobial therapies.